Ask the expert! We are pleased to host Dr. Swartzberg for this week’s virtual Curious Minds on Thursday, April 30 at 10:30 a.m. EDT. If you would like to submit a question in advance for Dr. Swartzberg to answer Thursday, please click here.
VIDEO: Watch the session here.
Like many other companies throughout the world, Ford has been navigating uncharted territory since the start of the COVID-19 global pandemic.
To protect the health and safety of our people and make sure we are moving forward with the most accurate and reliable information possible, Ford has enlisted the counsel of Dr. John Swartzberg, a renowned epidemiologist and specialist in infectious diseases and vaccines.
“Dr. Swartzberg is helping us analyze and interpret global data to determine the safest time for our people to return to work in different regions of the world,” said Ford Medical Director Dr. Walter Talamonti. “He also is advising us on best practices for testing, social distancing, cleaning Ford facilities and all other protocols and concerns related to COVID-19.”
Dr. Swartzberg is a clinical professor emeritus at University of California Berkeley’s School of Public Health in the Division of Infectious Diseases & Vaccinology, and he chairs the editorial board of the School of Public Health’s Health & Wellness Publications. He is board certified in internal medicine and infectious diseases. His 45-year career has been spent in clinical practice, research and teaching. He also is the hospital epidemiologist and chair of the infection control committee at the Alta Bates Medical Center in Berkeley.
He is board certified in internal medicine and infectious diseases. He spent 30 years in clinical practice before joining UC Berkeley’s faculty – part time since 1980 and full time since 2001. He also is the hospital epidemiologist and chair of the infection control committee at the Alta Bates Medical Center in Berkeley.
“Dr. Swartzberg has great insights,” said Dr. Talamonti. “He has a wealth of experiencing dealing with previous viruses like MERS and SARS and is a great resource to review what we’re doing and help us understand what to expect as we move forward.”